USP32 and ovarian cancer: Through analyzing the public epithelial ovarian cancer (EOC) microarray datasets and the in vivo shRNA screening dataset of Nakae et al. for novel therapeutic targets, USP32 was among the top-ranked genes which expressed in primary ovarian cancer and also deemed as a negative prognostic biomarker.